Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | RPS6KA2 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → RPS6KA2 |
| (<<) ACTG1 → RPS6KA2 |
| (<<) CCND1 → RPS6KA2 |
| (<<) DAB2 → RPS6KA2 |
| (<<) ELK3 → RPS6KA2 |
| (<<) EMP1 → RPS6KA2 |
| (<<) EPHA4 → RPS6KA2 |
| (<<) GNAQ → RPS6KA2 |
| (<<) GNG11 → RPS6KA2 |
| (<<) GSTM3 → RPS6KA2 |
| (<<) HGS → RPS6KA2 |
| (<<) HSPA4 → RPS6KA2 |
| (<<) KHDRBS1 → RPS6KA2 |
| (<<) KLK7 → RPS6KA2 |
| (<<) LIG1 → RPS6KA2 |
| (<<) LSM1 → RPS6KA2 |
| (<<) MAP3K5 → RPS6KA2 |
| (<<) MAPK1 → RPS6KA2 |
| (<<) MAPK14 → RPS6KA2 |
| (<<) MMP19 → RPS6KA2 |
| (<<) NFIL3 → RPS6KA2 |
| (<<) PDE2A → RPS6KA2 |
| (<<) PPAP2A → RPS6KA2 |
| (<<) PPP1CA → RPS6KA2 |
| (<<) PTMA → RPS6KA2 |
| (<<) PTRF → RPS6KA2 |
| (<<) RHOQ → RPS6KA2 |
| (<<) TK1 → RPS6KA2 |
| (<<) UBE2C → RPS6KA2 |
| (<<) UBE2D1 → RPS6KA2 |
| (<<) VEGFC → RPS6KA2 |
| Downstream (Children) |
|---|
| RPS6KA2 → ABLIM1 (>>) |
| RPS6KA2 → ADAM8 (>>) |
| RPS6KA2 → ATXN1 (>>) |
| RPS6KA2 → CREB5 (>>) |
| RPS6KA2 → DUSP6 (>>) |
| RPS6KA2 → GULP1 (>>) |
| RPS6KA2 → HYAL1 (>>) |
| RPS6KA2 → LIF (>>) |
| RPS6KA2 → NFATC1 (>>) |
| RPS6KA2 → NLGN4Y (>>) |
| RPS6KA2 → POP1 (>>) |
| RPS6KA2 → RND3 (>>) |
| RPS6KA2 → SOX18 (>>) |
| RPS6KA2 → TMC7 (>>) |
| RPS6KA2 → TNC (>>) |
| RPS6KA2 → TUBA1A (>>) |
